Skip to main content
search

UCI MIND Featured in the OC Register

UCI MIND Director, Dr. Joshua Grill was recently interviewed by the OC Register about the Institute’s role in being a reliable source of information about Alzheimer’s disease. Read the full article here

Related posts:

  1. FDA Advisory Panel meeting held to consider potential approval of donanemab Today, the FDA convened its Peripheral and Central Nervous System Drugs Advisory Committee to review the data from pivotal clinical trials of donanemab, a monoclonal antibody against the beta amyloid protein that accumulates in the brain of people with Alzheimer’s disease. One of these trials was conducted at UCI MIND....
  2. Celebrating Hispanic Heritage Month: Honoring Our Commitment to Alzheimer’s Research in Hispanic and Latino Communities This Hispanic Heritage Month, we proudly recognize the invaluable contributions of our faculty, staff, community partners, and supporters who are dedicated to addressing Alzheimer’s disease and related dementias in the Hispanic and Latino communities. Our mission to advance Alzheimer’s research is strengthened by the passion and collaboration of those working...
Close Menu